Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Miki

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Immunological Methods|August 9, 1993
Preparation of monoclonal antibodies against the IL-6 signal transducer, gp130, that can inhibit IL-6-mediated functionsT Saito, T Taga, D Miki, et al.
Journal of Biomedical Materials Research|November 15, 2000
Photocrosslinkable polysaccharides for in situ hydrogel formationK A Smeds, A Pfister-Serres, D Miki, et al.
Journal of Viral Hepatitis|May 20, 2014
Human microRNA hsa-miR-1231 suppresses hepatitis B virus replication by targeting core mRNAT Kohno, M Tsuge, E Murakami, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 1992
Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130T Taga, M Narazaki, K Yasukawa, et al.
Journal of Viral Hepatitis|January 14, 2012
Serum PAI-1 is a novel predictor for response to pegylated interferon-α-2b plus ribavirin therapy in chronic hepatitis C virus infectionD Miki, W Ohishi, H Ochi, et al.
Journal of Viral Hepatitis|June 17, 2014
Ribavirin dose reduction during telaprevir/ribavirin/peg-interferon therapy overcomes the effect of the ITPA gene polymorphismS Akamatsu, C N Hayes, M Tsuge, et al.
Journal of Viral Hepatitis|September 15, 2011
IL28B polymorphism may guide pegylated interferon plus ribavirin therapy even after curative treatment for hepatitis C virus-related hepatocellular carcinomaT Kawaoka, H Aikata, S Takaki, et al.
Journal of Viral Hepatitis|June 20, 2014
Emergence of resistant variants detected by ultra-deep sequencing after asunaprevir and daclatasvir combination therapy in patients infected with hepatitis C virus genotype 1K Kosaka, M Imamura, C N Hayes, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Immunological Methods|August 9, 1993
Preparation of monoclonal antibodies against the IL-6 signal transducer, gp130, that can inhibit IL-6-mediated functionsT Saito, T Taga, D Miki, et al.
Journal of Biomedical Materials Research|November 15, 2000
Photocrosslinkable polysaccharides for in situ hydrogel formationK A Smeds, A Pfister-Serres, D Miki, et al.
Journal of Viral Hepatitis|May 20, 2014
Human microRNA hsa-miR-1231 suppresses hepatitis B virus replication by targeting core mRNAT Kohno, M Tsuge, E Murakami, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 1992
Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130T Taga, M Narazaki, K Yasukawa, et al.
Journal of Viral Hepatitis|January 14, 2012
Serum PAI-1 is a novel predictor for response to pegylated interferon-α-2b plus ribavirin therapy in chronic hepatitis C virus infectionD Miki, W Ohishi, H Ochi, et al.
Journal of Viral Hepatitis|June 17, 2014
Ribavirin dose reduction during telaprevir/ribavirin/peg-interferon therapy overcomes the effect of the ITPA gene polymorphismS Akamatsu, C N Hayes, M Tsuge, et al.
Journal of Viral Hepatitis|September 15, 2011
IL28B polymorphism may guide pegylated interferon plus ribavirin therapy even after curative treatment for hepatitis C virus-related hepatocellular carcinomaT Kawaoka, H Aikata, S Takaki, et al.
Journal of Viral Hepatitis|June 20, 2014
Emergence of resistant variants detected by ultra-deep sequencing after asunaprevir and daclatasvir combination therapy in patients infected with hepatitis C virus genotype 1K Kosaka, M Imamura, C N Hayes, et al.
Pageof 2